StonvexLoading…
StonvexStonvexStonvexCore line items from COKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.23B | $6.90B | $6.65B | $6.20B |
Operating Income | $950.66M | $920.35M | $834.45M | $641.05M |
Net Income | $570.58M | $633.13M | $408.38M | $430.16M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $4.30B | $5.31B | $4.29B | $3.71B |
Total Liabilities | $5.04B | $3.90B | $2.85B | $2.59B |
Cash & Equivalents | $281.92M | $1.14B | $635.27M | $197.65M |
Free Cash Flow OCF − CapEx | $619.59M | $505.34M | $528.39M | $255.90M |
Shares Outstanding | Not available | Not available | Not available | Not available |